
Topic
Y90 Radioembolization
58 Podcasts • 35 Cases • 4 Courses on BackTable
Hear how experienced physicians approach Y90 Radioembolization on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 653 • 09 Jun 2026
Radiation Lobectomy Techniques & Downstaging for HCC
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases? In this episode of the BackTable 2026 HCC Creator Weekend™, host Dr. Kavi Krishnasamy is joined by interventional radiologists Dr. Beau Toskich and Dr. Chris Malone to explore how downstaging and radiation lobectomy with Y90 are creating new surgical and transplant opportunities for patients with limited future liver remnants. They discuss Y90’s role as a “test of time” for tumor biology, strategies to prevent post-hepatectomy liver failure, and the ongoing challenge of recurrence even after R0 resection in cirrhotic livers.
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
More on Y90 Radioembolization
Loading recent podcasts…
Vascular & IR # 653
Jun 9, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
Vascular & IR # 649
May 27, 2026
with Dr. Nima Kokabi, Dr. Riad Salem, Dr. Zach Berman
Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC...
1,100+ listens
Tumor Board # 59
May 12, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
190+ listens
Vascular & IR # 642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
70+ listens
Vascular & IR # 651
Jun 2, 2026
with Dr. Kirema Garcia-Reyes, Dr. Zach Berman, Dr. Nima Kokabi
What does it really take to run a high-volume Y90 program that is efficient, scalable, and patient-centered? In this...
970+ listens
Vascular & IR # 647
May 21, 2026
with Dr. Juan Gimenez, Dr. Ari Cohen, Dr. Jonathan Mizrahi
In treating hepatocellular carcinoma (HCC), the hardest question often isn’t which treatment to use, it’s who should...
20+ listens
Vascular & IR # 644
May 12, 2026
with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy
A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...
1,000+ listens
Vascular & IR # 641
May 5, 2026
with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow
With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...
1,900+ listens
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Jun 24, 2025
with Dr. Tyler Sandow, Dr. Nima Kokabi and Dr. Venkatesh Krishnasamy
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Aug 12, 2025
with Dr. Zach Berman and Dr. Christopher Beck
VI Case
Jul 1, 2025
with Dr. Nima Kokabi, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.





